Lynwood Capital Management’s BioCardia BCDA Stock Holding History

Lynwood Capital Management’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,595	Closed	-$344K	–	79
2023 Q2	$344K	Buy	+8,595	New	+$265K	0.44%	60

Other funds holding BCDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Lynwood Capital Management's BCDA Position: Q3 2023 in Review

Lynwood Capital Management sold out of BioCardia (BCDA) in Q3 2023, closing a stake of 8,595 shares — an estimated $344K sold.

Lynwood Capital Management first reported a position in BCDA in Q2 2023 and held it in 1 quarter. The position peaked at $344K in Q2 2023. 16 funds tracked by Wall St. Rank hold BCDA as of Q3 2023.

Lynwood Capital Management reported no remaining BioCardia position as of Q3 2023 after selling out during the quarter.
Lynwood Capital Management sold 8,595 BioCardia shares in Q3 2023, an estimated $344K.
Lynwood Capital Management first reported a position in BioCardia in Q2 2023 and held it in 1 quarter.
Lynwood Capital Management's BioCardia position peaked at $344K in Q2 2023.
16 funds tracked by Wall St. Rank held BioCardia as of Q3 2023.

Based on Lynwood Capital Management's 13F filing for Q3 2023, filed 1 Nov 2023.